Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Transcatheter aortic valve replacement (TAVR) is a transformative innovation that provides
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …

Transcatheter aortic valve implantation (TAVI) or replacement has rapidly changed the
treatment of patients with severe symptomatic aortic stenosis. It is now the standard of care …

Objectives Patients undergoing surgery for severe aortic stenosis (SAS) can be treated with
either transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement …

Background Few studies have yielded information on comparative effectiveness of
transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement …

Twelve years after the first transcatheter aortic valve implantation (TAVI) for severe aortic
stenosis (AS), European and American guidelines, as well as the FDA, indicated that TAVI is …

Transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation
(TAVI) has emerged as an attractive treatment strategy for the treatment of patients with …

Background Transcatheter aortic valve implantation/replacement (TAVI/TAVR) is becoming
more frequently used to treat aortic stenosis (AS), with increasing push for the procedure in …

Aims: Although transcatheter aortic valve implantation (TAVI) is officially indicated for severe
aortic stenosis (AS) patients at intermediate or higher surgical risk, the procedure is now …

In the last decade, transcatheter aortic valve implantation (TAVI), a disruptive technology,
has revolutionized the therapy of symptomatic severe aortic stenosis, and current guidelines …